πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

28 results for β€œJian Li” Clear

  1. HS-20094 Injection

    Jian Li

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  2. Irinotecan liposome、5-Fluorouracil、Leucovorin

    Jian Li

    Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy

    phase 3 small molecule completed

    1 trial

  3. Placebos

    Jian Li

    Advanced Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  4. SHR-1210

    Jian Li

    Locally Advanced or Metastatic and Unresectable HCC

    phase 3 small molecule completed

    1 trial

  5. HRS-6213

    Jian Li

    Patients With Solid Tumors

    phase 2 small molecule active

    1 trial

  6. High-Low Dose Radiotherapy

    Jian Li

    Nasopharyngeal Carcinoma (NPC)

    phase 2 other active

    1 trial

  7. Karelizumab combined with etoposide and cisplatin

    Jian Li

    Carcinoma

    phase 2 small molecule active

    1 trial

  8. Part1:Recombinant two-component COVID-19 vaccine (CHO cell)

    Jian Li

    COVID-19

    phase 2 mab completed

    1 trial

  9. SHR20004

    Jian Li

    Obesity

    phase 2 small molecule active

    1 trial

  10. 626

    Jian Li

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  11. 68Ga-FAPI-04

    Jian Li

    Fibrosis

    phase 1 small molecule active

    1 trial

  12. APL-1202 and APL-1501 (Single ascending dose)

    Jian Li

    Bladder Cancer

    phase 1 small molecule active

    1 trial

  13. Ad5-EBOV

    Jian Li

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  14. Daridorexant

    Jian Li

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  15. GST-HG121 tablets

    Jian Li

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

  16. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  17. HS-10345 84mg

    Jian Li

    Treatment Resistant Depressive Disorder

    phase 1 small molecule completed

    1 trial

  18. HS-10382(Part 1: Dose escalation)

    Jian Li

    CML, Chronic Phase

    phase 1 small molecule active

    1 trial

  19. Nemonoxacin

    Jian Li

    Kidney Dysfunction

    phase 1 small molecule active

    1 trial

  20. SHR-1501

    Jian Li

    Advanced Malignancies

    phase 1 small molecule completed

    1 trial

  21. SHR1459 tablet

    Jian Li

    B-cell Tumors

    phase 1 small molecule completed

    1 trial

  22. SHR2554 and Itraconazole

    Jian Li

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  23. [14C] HRS-9190

    Jian Li

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  24. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources